Amiloidózis: vizsgálatok itt: Egyesült Királyság

In Egyesült Királyság 20 Also abroad 184

20 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.

3. fázisTaking people
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Where
Birmingham, Cardiff, Glasgow, Hexham, Liverpool, London, Manchester
Életkor
18 év to 90 év
People
1200 worldwide
Run by
Intellia Therapeutics
See details and how to joinNCT06128629 · EU 2023-507220-23-00
No phaseTaking people
Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis
Where
Glasgow
Életkor
18 év and over
People
2200 worldwide
Run by
Idoven 1903 S.L.
See details and how to joinNCT06978660
1. fázisTaking people
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Where
London, Sutton
Életkor
18 év and over
People
180 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT05652335 · EU 2023-503679-12-00
2. fázisTaking people
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
Where
Liverpool, London
Életkor
18 év to 64 év
People
60 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07224672 · EU 2025-522803-60-00
3. fázisCsak meghívásos
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Where
Bellshill, Birmingham, Cardiff, Hexham, London, Manchester
Életkor
18 év and over
People
700 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT06679946
3. fázisTaking people
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Where
Bellshill, Birmingham, Cardiff, Liverpool, London, Manchester
Életkor
18 év and over
People
1280 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07207811
3. fázisTaking people
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Where
Bellshill, Birmingham, Cardiff, London, Manchester
Életkor
18 év to 85 év
People
1750 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT07052903 · EU 2024-519917-72-00
3. fázisTaking people
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Where
London
Életkor
18 év to 85 év
People
125 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT07223203 · EU 2025-522544-40-00
No phaseTaking people
A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
Where
Multiple Locations
Életkor
18 év and over
People
2000 worldwide
Run by
Bayer
See details and how to joinNCT07235462
No phaseTaking people
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Where
Birmingham, Glasgow, London
Életkor
18 év to 130 év
People
1850 worldwide
Run by
AstraZeneca
See details and how to joinNCT06465810
No phaseTaking people
Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations
Where
Birmingham
Életkor
18 év and over
People
320 worldwide
Run by
AstraZeneca
See details and how to joinNCT07654855
No phaseTaking people
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
Where
London
People
52 121 worldwide
Run by
AstraZeneca
See details and how to joinNCT06355934
3. fázisNot yet taking people in Egyesült Királyság
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
Where
Birmingham, Cardiff, Glasgow, London, Manchester
People
1180 worldwide
Run by
Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07789483 · EU 2026-526755-57-00
1/2. fázisTaking people
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Where
London, Manchester
Életkor
18 év and over
People
220 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06292780 · EU 2023-507809-34-00
3. fázisTaking people
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Where
London
Életkor
18 év to 75 év
People
587 worldwide
Run by
Eidos Therapeutics, a BridgeBio company
See details and how to joinNCT06563895 · EU 2024-513547-82-00
2/3. fázisCsak meghívásos
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
Where
London
Életkor
18 év and over
People
72 worldwide
Run by
Intellia Therapeutics
See details and how to joinNCT05697861 · EU 2023-507385-11-00
1/2. fázisTaking people
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
Where
London
Életkor
18 év and over
People
91 worldwide
Run by
Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07081646
No phaseTaking people
PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY
Where
London
Életkor
18 év and over
People
320
Run by
Richmond Research Institute
See details and how to joinNCT05098665
3. fázisCsak meghívásos
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Where
Bellshill, Cardiff, Edgbaston, Hampstead, Liverpool, London, Manchester
Életkor
18 év and over
People
1400 worldwide
Run by
Ionis Pharmaceuticals, Inc.
See details and how to joinNCT05667493
No phaseTaking people
National Registry of Rare Kidney Diseases
Where
Bristol
People
35 000
Run by
UK Kidney Association
See details and how to joinNCT06065852